12R-lipoxygenase (12R-LOX) represents a key enzyme of a recently identified eicosanoid pathway in the skin that plays an essential role in the establishment and/or maintenance of the epidermal barrier function. Genetic studies show that loss-of-function mutations in ALOX12B, encoding 12R-LOX, and in ALOXE3, encoding another closely related LOX involved in this pathway, are the second most common cause for autosomal recessive congenital ichthyosis (ARCI). To investigate the pathomechanism of ARCI and the function of 12R-LOX, we recently generated a 12R-LOX knockout model. 12R-LOX-deficient mice die rapidly after birth from severe barrier dysfunction without exhibiting an obvious cutaneous phenotype. Thus, we analyzed the adult phenotype of 12R-LOX À/À skin transplanted onto nude mice. 12R-LOX À/À skin develops an ichthyosiform appearance with thickening of the epidermis, hyperproliferation, hypergranulosis, focal parakeratosis, and severe hyperkeratosis. The adult mutant mouse skin phenotype closely reproduces the ichthyosis phenotype seen in patients with ALOX12B mutations. Western blot analysis revealed restoration of profilaggrin processing that used to be disturbed in neonatal mutant skin and overexpression of filaggrin, involucrin, and repetin. The results indicate that 12R-LOX knockout mice may represent a useful animal model for a detailed analysis of mechanisms involved in ARCI forms that are associated with impaired LOX metabolism.
INTRODUCTION
Autosomal recessive congenital ichthyoses (ARCI), including lamellar ichthyosis and nonbullous congenital ichthyosiform erythroderma form a clinically and genetically heterogeneous group of severe keratinization disorders that are associated with impaired skin barrier function (Traupe, 1989; Oji and Traupe, 2006) . It is a severe condition with an estimated prevalence of one in 200,000 newborns. The disease is characterized by intense scaling of the whole integument, different in color and shape, and is sometimes associated with erythema. Affected individuals are often born as collodion babies encased in a tough inelastic membrane. Histological features of the epidermis in ARCI are nonspecific, but typically include a compensatory thickening of the stratum corneum and epidermal hyperplasia. Ultrastructurally, several types of distinct morphological markers can be differentiated, part of them corresponding to specific molecular genetic constellations (Pigg et al., 1998; Akiyama et al., 2006; Melin et al., 2006; Dahlqvist et al., 2007) .
In nonsyndromic ARCI so far, six different genes have been identified that cause the observed phenotype (Oji and Traupe, 2006) . The corresponding proteins are involved in the production, transport, or assembly of components of the stratum corneum that constitutes the permeability barrier of the skin. TGM1 (OMIM 190195)-encoding transglutaminase 1 is implicated in the crosslinking of structural proteins and lipids forming the cornified cell envelope. ABCA12 (OMIM 607800) that is mutated in lamellar ichthyosis type 2 and harlequin ichthyosis encodes a lipid transporter critically involved in the maturation and secretion of lamellar bodies. The other recently identified ARCI genes including the lipoxygenase (LOX) genes ALOX12B (OMIM 603741) and ALOXE3 (OMIM 607206), a recently identified cytochrom P450 gene CYP4F22 (OMIM 611495) and a putative receptor gene ichthyin (OMIM 609383) have been suspected to be part of a common lipid pathway (Lefevre et al., 2006) .
ALOX12B and ALOXE3 encoding 12R-LOX and epidermis-type LOX-3 are members of the epidermal subfamily of mammalian LOX with preferential expression in skin and several other epithelial tissues (Krieg et al., 2002) . LOX represents a widespread family of nonheme iron dioxygenases that insert molecular oxygen into polyunsaturated fatty acids thus producing highly active lipid mediators (Brash, 1999) . 12R-LOX and epidermis-type LOX-3 differ from all other LOX by unusual structural and enzymatic features. 12R-LOX represents the only mammalian LOX that forms products with R-chirality and, unlike all other LOX, epidermis-type LOX-3 does not exhibit dioxygenase activity but functions as a hydroperoxide isomerase Krieg et al., 1999; Yu et al., 2003) . Both enzymes act in sequence to convert arachidonic acid via 12R-hydroperoxyeicosatetraenoic acid to the corresponding hepoxilin-like epoxyalcohol, 8R-hydroxy-11R,12R-epoxyeicosatrienoic acid .
Mutations in ALOX12B or ALOXE3 have been identified in about 10% of ARCI patients (Jobard et al., 2002; Eckl et al., 2005; Lesueur et al., 2007) . We and others have shown that the mutations found completely eliminated the catalytic activity of the LOX enzymes, indicating that mutational inactivation of either 12R-LOX or epidermis-type LOX-3 is causally linked to the ARCI phenotype (Eckl et al., 2005; Yu et al., 2005) .
To analyze the molecular mechanisms that underlie the ichthyosiform skin phenotype, we recently developed an animal model with targeted inactivation of the 12R-LOX gene in mice (Epp et al., 2007) . 12R-LOX deficiency in these mice and similarly in another mouse model harboring a loss-offunction mutation in Alox12b (Moran et al., 2007) leads to a postnatal lethal phenotype due to a severely impaired inward and outward permeability barrier function. Probably because of their short lifespan 12R-LOX-deficient mice do not develop a typical ichthyosiform skin phenotype.
In this study, we have analyzed the adult 12R-LOX knockout phenotype in skin transplants on the back of nude mice. We show that skin lacking 12R-LOX function develops an adult phenotype that recapitulates the typical compensatory responses to impaired epidermal barrier function observed in ichthyosis patients including hyperproliferation, hypergranulosis, and marked hyperkeratosis.
RESULTS
Ichthyosiform phenotype of mature Alox12b-deficient mouse skin Macroscopically, Alox12b-deficient neonates do not develop a gross skin because they die within 3-5 hours after birth (Epp et al., 2007) . As shown in this study, an adult ichthyosiform phenotype develops in skin from Alox12b À/À grafted onto the back of nude mice. At 4 weeks after transplantation, the grafts were covered with normal hair (Figure 1a and b). Macroscopically, no significant differences were apparent between knockout and control grafts. At the level of hematoxylin/eosin-stained paraffin section images the histology of control skin grafts on nude mice was similar to that of normal adult mouse skin with a thin epidermis that consists of 2-3 nucleated cell layers without visible stratum granulosum (Figure 1 c) . In contrast, skin grafted from Alox12b-deficient neonates was considerably thicker exhibiting a hyperplastic phenotype with epidermal acanthosis and pronounced hyperkeratosis ( Figure 1d ).
Ultrastructural analysis
Electron microscopy confirmed hyperkeratosis at the ultrastructural level. As compared with control skin grafts, the stratum corneum of skins grafted from Alox12b-deficient mice was markedly piled up in over 30 layers (Figure 2a and b). Of note, lipid droplets and occasionally remnants of cellular components, e.g, of nuclei were observed in corneocytes of the mutant skin grafts but not of the control grafts (Figure 2c and d ). In addition, deposits resembling extruded contents of lamellar bodies in the transient zone were seen in the intercellular spaces of higher stratum corneum levels of mutant skin grafts suggesting disturbed extrusion or processing of lamellar bodies. Furthermore, both the size and the number of keratohyaline granules were increased indicating hypergranulosis in mutant skin grafts ( Figure 2b ). The characteristic vacuole-like anomalies observed in the granular layers of neonatal Alox12b-deficient skin, however, could not be detected in the grafted adult mutant skin.
Alox12b-deficient skin grafts exhibit a hyperproliferative phenotype
The epidermal proliferation index of the grafted skin was determined by immunofluorescence analysis as the percentage of Ki67-staining nuclei in the epidermis (Figure 3a and b). Ki67-positive cells were significantly increased in the mutant grafts as compared to the control grafts (63.4 ± 3.2% vs 46.4 ± 0.6% in knockout and control mice, respectively), which indicates a significant hyperproliferation of the epidermis. Although in control grafts, all Ki67-positive cells remain restricted to the basal cell layer, Ki67-staining nuclei were occasionally observed in the first suprabasal layer of mutant skin grafts ( Figure 3b ). Consistently with epidermal hyperproliferation, a strong expression of keratin K6 was observed in basal and suprabasal layers of the mutant skin graft but only focally in those of control grafts (Figure 3c and d) .
Overexpression of CE proteins
The expression of epidermal keratin and terminal differentiation markers in the skin grafts was evaluated by immunofluorescence and western blotting. Basal cell-specific keratin K14 was present at similar levels showing a comparable immunostaining pattern in mutant and control skin grafts (Figure 4a and b). Strong expression of keratin K10 was observed in all living suprabasal cell layers, but appeared much broader in the transplants from the Alox12b-deficient skin (Figure 4c and d) . Similarly, proteins of the cornified envelope (CE) such as involucrin, repetin, and filaggrin were seen in their typical localizations in both control and mutant skin grafts, with the consistent difference, however, that the staining was stronger and the number of cell layers showing immunostaining of these proteins was higher in the grafts from Alox12b-deficient mice (Figure 4e -j). Consistently with these observations, western blot analysis demonstrated a markedly increased expression of these CE proteins and K6 in mutant skin grafts as compared to wild-type transplants, although the levels of K5 and K10 were the similar in both genotypes (Figure 5a ). Most interestingly, in addition to a strong overexpression of profilaggrin precursor intermediates also highly increased levels of fully processed filaggrin monomers were detected that indicates complete profilaggrin processing in the mutant adult skin grafts in contrast to the neonatal Alox12b-deficient skin that previously has been shown to completely lack mature filaggrin monomers ( Figure 5b ).
Increased transepidermal water loss
The barrier function in the transplanted skin was assessed by measuring transepidermal water loss (TEWL). TEWL in the grafted control skin was 3.2 ± 0.2 g m À2 per hour, a level similar to that found in normal neonatal skin (2.6±0.2g m À2 per hour). The TEWL levels of grafted mature Alox12bdeficient skin was about threefold higher (7.9±0.3 g m À2 per hour), but significantly reduced as compared to the levels of Alox12b À/À neonates (14.4 ± 0.3 g m À2 per hour, (Epp et al., 2007) .
DISCUSSION
Loss-of-function mutations in ALOX12B and ALOXE3 are the second most common cause for ARCI (Jobard et al., 2002; Eckl et al., 2005; Lesueur et al., 2007; Harting et al., 2008) . Recently, we have generated Alox12b knockout mice as a human disease model for ARCI (Epp et al., 2007) . Mice with Alox12b deficiency die rapidly after birth as a result of severe dehydration. In fact, gene defects that disrupt barrier function are known to cause a more severe phenotype in the mouse than in human skin as a result of the much larger surface to volume ratio. Morphologically, however, the newborn knockout mice do not exhibit an obvious cutaneous phenotype.
In this study, we demonstrate that Alox12b-deficient mouse skin that matures after transplantation onto nude mice reveals an ichthyosiform appearance with thickening of the epidermis, hyperproliferation, hypergranulosis, parakeratosis, and severe hyperkeratosis. These features represent typical compensatory mechanisms observed in the adult epidermis of other deficient mice suffering from severe skin barrier defects and recapitulate the phenotype observed in skin from ichthyosis patients (Segre, 2003; Oji and Traupe, 2006) . Compensatory pathological epidermal mechanisms such as these primarily serve to counteract an increased loss of water through the skin. In fact, presumably as a result of the massive hyperkeratosis, the TEWL of the adult transplants from Alox12b-deficient skin is considerably decreased as compared to neonatal knockout skin, but still significantly higher than in the control skin grafts. Although in many mouse models with defective barrier function, a cutaneous phenotype is already apparent at birth, the development of hyperplasia and thickening of the stratum corneum in the 12R-LOX knockout skin might represent later response processes, a feature that was also observed in TGase1deficient mice (Kuramoto et al., 2002) . Skin grafts from TGase1 À/À mice and from other mice with barrier defects, however, typically show alopecia, marked erythema, and massive scales (Furuse et al., 2002; Stone et al., 2004; Descargues et al., 2005) . 12R-LOX knockout grafts, in contrast, exhibit normal hair growth, no erythema and mild scaling. This macroscopic appearance closely reproduces the mild phenotype seen in many patients with ALOX12B mutations that is characterized by moderate light scaling with no or moderate erythema (Jobard et al., 2002; Eckl et al., 2005; Lesueur et al., 2007; Harting et al., 2008) . On the other hand a more severe phenotype with intense lamellar scaling and large brown scales as well as even a self-healing collodion baby phenotype (Harting et al., 2008) was observed in other patients with ALOX12B mutations confirming clinical heterogeneity of ARCI. Heterogeneity is also manifested on the histopathological and even more on the ultrastuctural level. To date, there are only two reports in the literature on the morphological features of skin biopsies from patients with ALOX12B mutations. Histologically, the mouse skin grafts closely resemble the phenotype of a patient exhibiting the clinical features of self-healing collodion membrane (Harting et al., 2008) . The skin biopsy taken 3 days after birth at the edge of the collodion membrane showed a thickened orthokeratotic stratum corneum containing numerous cytoplasmic droplets and increased prominence of the granular layer with underlying mild acanthosis. In another report, the histological analyses of two patients with ALOX12B mutations similarly showed orthokeratotic hyperkeratosis but reduced or absent stratum granulosum (Lesueur et al., 2007) . Respective studies of our group have revealed further diversity of the morphological phenotype.
More comprehensive morphological analyses of skin biopsies from patients with ALOX12B mutations are needed to further clarify similarities and differences between the Alox12bdeficient mouse skin and human patient skin. A characteristic ultrastructural feature of the neonatal 12R-LOX knockout skin is the presence of vacuole-like structures in the upper granular cells, the appearance of which resembles those functioning as reliable ultrastructural markers in a distinct group of ARCI patients (Dahlqvist et al., 2007; Epp et al., 2007) . Our suggestion was that loss of barrier function may be caused by a disturbance of the normal processing of lamellar bodies that is essential for the formation of intercellular lipid structures. Consistent with a pathogenic role of a disturbed lipid metabolism, we furthermore observed significant alterations in the composition of ester-bound ceramides in the neonatal knockout skin. In this study, however, a comprehensive lipid analysis was not feasible because of the small size of the skin grafts. In addition, electron microscopic examination of the adult skin grafts does not reveal any of the above-described vacuolelike structures suggesting that these might be caused by some dysfunctional/disruptive and perhaps secondary process overcome in the transplants possibly by environmental/ compensating effects of the surrounding host tissue but present after birth in the neonatal skin. We observe, however, occasionally deposits of cytoplasmatic material within the intercellular space of the stratum corneum lamellae of mutant skin grafts, with the same appearance as extruded contents of lamellar bodies in the transition area supporting the proposed hypothesis that 12R-LOX deficiency might affect processing of lamellar bodies. Another remarkable feature of the adult skin graft as compared to the newborn mutant skin is a restoration of the filaggrin processing. As previously shown, 12R-LOX-deficient newborn skin completely lacks mature filaggrin monomers, a defect that considerably might contribute to the early neonatal death. Disturbance of profilaggrin processing is also observed in several other mouse models with defective barrier function and in humans a lack of proteolytically processed filaggrin monomers has been shown to underlie ichthyosis vulgaris and suggested to be a major predisposing factor for atopic dermatitis (Presland et al., 2000; List et al., 2002; Descargues et al., 2005; Leyvraz et al., 2005; Sandilands et al., 2006; Smith et al., 2006) . The processing of profilaggrin to filaggrin and the final proteolytic steps of filaggrin degradation is a complex and yet poorly understood cascade during late differentiation that requires the coordinated activity of various enzymes including phosphatases, proteases, and protease inhibitors. In which way, any of these steps is affected by 12R-LOX deficiency is currently unknown. The reappearance of filaggrin monomers in adult skin grafts could possibly be explained by a diffusible host factor that compensates for the defect evoked by 12R-LOX deficiency in the neonatal knockout skin.
Western blot analysis not only indicated unimpaired profilaggrin processing in the adult knockout skin grafts but also, as compared to control grafts, a strong overexpression of filaggrin and two other CE proteins, involucrin, and repetin, whereas keratin expression was unchanged. Involucrin represents a major CE scaffold protein while repetin, another member of the multifunctional fused gene family profilaggrin belongs to, is a minor structural CE component commonly expressed in toughened epithelia and during wound healing (Krieg et al., 1997; Cooper et al., 2005) . Compensatory upregulation of repetin in response to barrier disturbance has earlier been observed in the skin of loricrin-deficient mice (Koch et al., 2000) . The genes of filaggrin, involucrin, and repetin are localized close together within the highly conserved epidermal differentiation complex, suggesting a coordinate upregulation of these genes. Such a coordinated upregulation of genes within the epidermal differentiation complex has been reported from mice with targeted ablation of the transcription factor klf4 where 12 of the 15 members of the small proline-rich protein gene family (sprr) were found to be upregulated in response to the severe barrier dysfunction in these mice (Patel et al., 2003) . It remains to be evaluated whether the expression of sprr and/or other genes of the epidermal differentiation complex is misregulated in 12R-LOX-deficient skin in a similar manner.
In summary, this study shows that mature 12R-LOXdeficient mouse skin develops an ichthyosiform phenotype that closely resembles the phenotype observed in ichthyosis patients indicating that 12R-LOX knockout mice represent a suitable animal model for ARCI forms associated with an impaired LOX metabolism. Work is currently in progress on a more comprehensive analysis of the adult 12R-LOX-deficient skin phenotype by using a refined conditional knockout model with inducible keratinocyte-specific gene inactivation in which the molecular mechanisms of LOX action and the pathomechanisms of ichthyosis as well as future putative therapeutic approaches can be investigated.
MATERIALS AND METHODS

Animals
The animal experiments were performed in accordance with the guidelines of the Arbeitsgemeinschaft der Tierschutzbeauftragten in Baden-Wü rttemberg (Officials for Animal Welfare) and were approved by the Regierungspräsidium Karlsruhe, Germany. All animals used for this study were kept at the central animal facility of the German Cancer Research Center. Animals were maintained under pathogen-free conditions, an artificial day/night rhythm and were feed standard food pellets (Altromin, Lage, Germany), with sterile water available ad libitum. Alox12b À/À mice were generated by intercrossing of heterozygous mutant mice and genotyping was performed by PCR as described previously (Epp et al., 2007) .
Skin grafting
In total, 17 control and 15 Alox12b À/À newborn were killed by decapitation, and their dorsal skins were excised and transplanted onto nude mice using a slightly modified skin-flap technique (Barrandon et al., 1988) . Those grafted skins were fully adapted within 2 weeks of grafting. At 4 weeks after transplantation they were harvested for the analysis.
Antibodies
Mouse monoclonal anti-12R-LOX antibody has been described earlier (Epp et al., 2007) . Other primary antibodies used were mouse anti-GAPDH (Santa Cruz Biotechnology, Heidelberg, Germany), mouse anti-filaggrin (Abcam, Cambridge, UK), rabbit anti-repetin, rabbit anti-keratin 5, rabbit anti-keratin 10, rabbit anti-involucrin, guinea pig anti-keratin 14 (all BabCo, Richmond, CA), mouse anti-Ki67 (Innovative Diagnostik-Systeme, Hamburg, Germany), and mouse anti-keratin 6 (Covance, Princeton, NJ). Secondary antibodies were Alexa Fluor 488 goat anti-mouse IgG (Invitrogen, Karlsruhe, Germany), CY3 anti-rabbit IgG (BD Biosciences, Heidelberg, Germany), CY3 anti-guinea pig (Jackson ImmunoResearch, Suffolk, UK), anti-goat antibodies (Santa Cruz Biotechnology), and horseradish peroxidase-conjugated anti-rabbit (BD Biosciences).
Epidermal protein extraction and Western blot analysis
Skin was extended on paper and immediately frozen in liquid nitrogen. Epidermis was mechanically separated from the dermis by scratching. Then epidermis was homogenized in ice-cold lysis buffer containing 1% TritonX-100, 0.5% deoxycholate, 0.1% SDS, 2 mM EDTA, 10% Glycerol, 150 mM NaCl, 50 mM Tris, pH 7.4, and protein inhibitors (1 mM phenylmethanesulphonylfluoride, aprotinin 1 mg ml À1 , and leupeptin 1 mg ml À1 ). Western blot analysis was performed as previously described (Epp et al., 2007) .
Histological and immunohistochemical analysis
For light microscopic observation, samples were fixed for 24 h with 4% formalin in phosphate-buffered saline (PBS), dehydrated in 70% ethanol, and then embedded in paraffin. Five-mm sections were mounted on slides, dewaxed, rehydrated, and stained with hematoxylin/eosin. For immunofluorescence microscopy, 5-mm cryosections were fixed in acetone for 10 minutes at À20 1C and then permeabilized with 0.05% Triton X-100 in PBS and flushed with PBS. The slides were blocked in 1% BSA in PBS for 1 h and then incubated with the primary antibody for 1 h. After washing three times (10 minutes each) in PBS, samples were incubated with a fluorescent dye-coupled antibody and Hoechst 33258 diluted in blocking buffer for 30 minutes and washed as described above. Sections were embedded in mounting medium (DakoCytomation, Hamburg, Germany) and examined by light microscopy using a photomicroscope (Zeiss Axioplan2, Gö ttingne, Germany) with a Zeiss Â 25 Plan-Neofuar objective. Images were acquired with a high sensibility digital black/white AxioCam (Zeiss).
Measurement of transepidermal water loss
The rate of TEWL from the skin transplants was determined using a Tewameter (Courage and Khazaka, Cologne, Germany) under normal conditions. Data are expressed in g m À2 per hour.
Electron microscopy
All specimens were fixed for at least 2 h at room temperature in 3% glutaraldehyde solution in 0.1. cacodylate buffer, pH 7.4, cut into pieces of B1 mm 3 , washed in buffer, postfixed for 1 h at 41 in 1% osmium tetroxide, rinsed in water, dehydrated through graded ethanol solutions, transferred into propylene oxide, and embedded in epoxy resin (glycidether 100). Ultrathin sections were cut with an ultramicrotome (Reichert Ultracut E, Depew, NY), treated with uranyl acetate and lead citrate, and examined with an electron microscope (Philips EM 400, Eindhoven, The Netherlands). 
